SPACInsider Logo
FinTech V (FTCV) Terminates eToro Deal
by Marlena Haddad on 2022-07-05 at 9:00am

FinTech V (NASDAQ:FTCV) announced this morning that it has mutually terminated its combination agreement with social investing network eToro.

While most SPACs that have recently terminated their deals have pointed towards current market conditions as the main culprit, Fintech V disclosed that it was unable to meet certain closing conditions and specifically, “the Company’s registration statement, within the timeframe outlined by the Merger Agreement and as extended by the Merger Agreement Amendment”.

This transaction was originally announced back in March of 2021, nearly 16 months ago, but had still not been able to get its proxy approved by the SEC so it could set a shareholder vote date. As a result, it missed its original Outside Date, which was then extended to June 30, 2022.  Betsy Cohen, Chairman of FinTech V, noted that the transaction was impracticable “due to circumstances outside of either party’s control.”

Fortunately, neither party will be required to pay the other a termination fee as a result of the mutual decision to terminate the Merger Agreement.

FinTech V originally was planning to finance the deal with the $250 million in its current trust along with a $650 million PIPE at $10 per share. The PIPE drew investment from ION Investment Group, Softbank Vision Fund 2, Third Point LLC, Fidelity Management & Research Company LLC, and Wellington Management.  eToro had planned to add $525 million of the proceeds to its balance sheet while passing a $300 million cash consideration to its shareholders.

Going forward, Fintech V has a completion deadline of December 8, 2022, or roughly five months to find a new target.

The SPAC initially announced its $9.6 billion combination with eToro on March 16, 2021. eToro is an online multi-asset investment platform with features like social investing and proprietary “smart portfolios.”

 

Recent Posts
by Kristi Marvin on 2023-01-28 at 1:59pm

Terms Tracker for the Week Ending January 27, 2022 Welcome to our weekly column where we discuss the findings from our IPO terms tracker based on the previous week’s pricings. We’re coming up on the end of January, the first month of the year, and to-date no new S-1s have been filed. Additionally, the number...

by Marlena Haddad on 2023-01-27 at 11:34am

  Below is a daily summary of links to the latest SPAC news and rumors gathered across the web.  Latest SPAC News: Circle spokesperson denies blaming SEC for failed deal, BuzzFeed CEO says AI-powered content will be part of core business, and FaZe Clan faces possible delisting Circle Spokesperson Denies Blaming SEC for Failed $9 Billion Deal...

by Nicholas Alan Clayton on 2023-01-27 at 10:00am

Health Sciences 2 (NASDAQ:HSAQ) announced that it closed its combination with Orchestra BioMed on January 26. HSAQ ahead of its vote pre-announced redemption figures of 1,597,888 shares equating to 67.7% redemptions, however, that’s still subject to change.  However, today it was noted that Orchestra BioMed is to receive $70 million in gross proceeds including $20...

by Kristi Marvin on 2023-01-27 at 7:33am

Carbon capture technology has long been talked about, and it is finally in operation with LanzaTech among the pioneers. Its plants are turning potential emissions into clothing, household goods and sustainable fuels. SPAC cash is now also an accelerant in this new process as the company announced a $1.7 billion combination with AMCI II last March. This week, we caught up with...

by Nicholas Alan Clayton on 2023-01-27 at 7:30am

In this series we’ll be examining successful SPAC deals from the past both in the terms and circumstances of their de-SPAC processes and how they have weathered the storms that have followed after their public listings with research from SPACInsider contributor Anthony Sozzi. Thirty months does not sound like that long, but it’s been a...

Privacy Policy|Terms Of Use
Copyright © 2022 SPACInsider, Inc. All Rights Reserved